{
  "_originalData": {
    "identity": {
      "bacteriumName": "Gram-Negative Bacilli",
      "aliases": [
        "GNB"
      ],
      "lastUpdated": "2024-09-30",
      "clsiCategory": "Overview",
      "classification": {
        "gramStain": "Gram-negative",
        "morphology": "Rod",
        "respiration": "Variable",
        "notes": []
      },
      "strainDetails": [],
      "biochemicalTests": "This is an overview document and does not pertain to a single organism."
    },
    "clinicalProfile": {
      "summary": "This document provides an overview of beta-lactam resistance mechanisms in Gram-negative bacilli, which are a major cause of healthcare-associated and community-acquired infections. Resistance to beta-lactam antibiotics (penicillins, cephalosporins, carbapenems) is a significant clinical challenge.",
      "pathophysiologyPearls": [],
      "keySignsAndSymptoms": [],
      "clinicalSyndromes": [],
      "highRiskPopulations": [],
      "transmissionVectors": [],
      "prognosisNotes": []
    },
    "resistanceProfile": {
      "groupIntrinsicResistance": [],
      "intrinsicResistance": [],
      "majorMechanisms": [
        {
          "mechanismName": "Beta-lactamase Production",
          "mechanismType": "Enzymatic degradation",
          "description": "Production of enzymes that hydrolyze the beta-lactam ring, inactivating the antibiotic. This is the most common mechanism of resistance."
        },
        {
          "mechanismName": "Decreased Permeability",
          "mechanismType": "Porin mutation",
          "description": "Mutations in porin proteins in the outer membrane reduce the entry of beta-lactam antibiotics into the bacterial cell."
        },
        {
          "mechanismName": "Efflux Pumps",
          "mechanismType": "Active transport",
          "description": "Active transport systems that pump antibiotics out of the bacterial cell."
        },
        {
          "mechanismName": "Altered Penicillin-Binding Proteins (PBPs)",
          "mechanismType": "Target modification",
          "description": "Mutations in the target PBPs reduce the binding affinity of beta-lactam antibiotics."
        }
      ],
      "clinicalAlerts": [
        {
          "alertTitle": "Co-resistance",
          "details": "Resistance to beta-lactams is often associated with concomitant resistance to other antibiotic classes, such as fluoroquinolones, tetracyclines, TMP-SMX, and aminoglycosides."
        }
      ]
    },
    "treatment": {
      "generalNotes": [
        "Treatment of infections caused by multi-drug resistant Gram-negative bacilli is complex and often requires consultation with an infectious diseases specialist.",
        "The choice of therapy depends on the specific resistance mechanism (e.g., ESBL, KPC, MBL, OXA) and the site of infection."
      ],
      "drugsToAvoid": [],
      "adjunctiveTherapies": [],
      "regimens": []
    },
    "laboratoryProfile": {
      "testingIndications": [],
      "methodologyNotes": [
        "Phenotypic methods are used to detect carbapenemase-producing bacteria in the clinical laboratory."
      ],
      "recommendedPanel": [],
      "specialTests": [],
      "reportingRules": [],
      "antimicrobialBreakpoints": []
    },
    "additionalInformation": {
      "diagnosticNotes": {
        "summary": "",
        "biosafetyWarning": "",
        "methods": []
      },
      "preventionAndScreening": [],
      "treatmentLifecycle": [],
      "antimicrobialStewardship": [],
      "drugSpecificPearls": [],
      "guidelineReferences": [
        {
          "source": "IDSA",
          "citation": "2024 Updated IDSA Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections",
          "summaryOrNote": "Provides comprehensive recommendations for the treatment of infections caused by ESBL-producing, AmpC-producing, and carbapenemase-producing Gram-negative bacilli."
        }
      ]
    }
  },
  "_metadata": {
    "originalKeys": [
      "identity",
      "clinicalProfile",
      "resistanceProfile",
      "treatment",
      "laboratoryProfile",
      "additionalInformation"
    ],
    "conversionTimestamp": "2025-07-15T03:16:49.381Z",
    "sourceFormat": "modern"
  },
  "identity": {
    "bacteriumName": {
      "sources": [
        "identity.bacteriumName"
      ],
      "value": "Gram-Negative Bacilli"
    },
    "aliases": {
      "sources": [
        "identity.aliases"
      ],
      "value": [
        "GNB"
      ]
    },
    "lastUpdated": {
      "sources": [
        "identity.lastUpdated"
      ],
      "value": "2024-09-30"
    },
    "classification": {
      "sources": [
        "identity.classification"
      ],
      "value": {
        "gramStain": "Gram-negative",
        "morphology": "Rod",
        "respiration": "Variable",
        "notes": []
      }
    }
  },
  "clinicalInformation": {
    "sources": [
      "clinicalProfile"
    ],
    "value": {
      "summary": "This document provides an overview of beta-lactam resistance mechanisms in Gram-negative bacilli, which are a major cause of healthcare-associated and community-acquired infections. Resistance to beta-lactam antibiotics (penicillins, cephalosporins, carbapenems) is a significant clinical challenge.",
      "pathophysiologyPearls": [],
      "keySignsAndSymptoms": [],
      "clinicalSyndromes": [],
      "highRiskPopulations": [],
      "transmissionVectors": [],
      "prognosisNotes": []
    }
  },
  "resistanceInformation": {
    "sources": [
      "resistanceProfile"
    ],
    "value": {
      "groupIntrinsicResistance": [],
      "intrinsicResistance": [],
      "majorMechanisms": [
        {
          "mechanismName": "Beta-lactamase Production",
          "mechanismType": "Enzymatic degradation",
          "description": "Production of enzymes that hydrolyze the beta-lactam ring, inactivating the antibiotic. This is the most common mechanism of resistance."
        },
        {
          "mechanismName": "Decreased Permeability",
          "mechanismType": "Porin mutation",
          "description": "Mutations in porin proteins in the outer membrane reduce the entry of beta-lactam antibiotics into the bacterial cell."
        },
        {
          "mechanismName": "Efflux Pumps",
          "mechanismType": "Active transport",
          "description": "Active transport systems that pump antibiotics out of the bacterial cell."
        },
        {
          "mechanismName": "Altered Penicillin-Binding Proteins (PBPs)",
          "mechanismType": "Target modification",
          "description": "Mutations in the target PBPs reduce the binding affinity of beta-lactam antibiotics."
        }
      ],
      "clinicalAlerts": [
        {
          "alertTitle": "Co-resistance",
          "details": "Resistance to beta-lactams is often associated with concomitant resistance to other antibiotic classes, such as fluoroquinolones, tetracyclines, TMP-SMX, and aminoglycosides."
        }
      ]
    }
  },
  "treatmentData": {
    "treatmentData": {
      "_treatmentMetadata": {
        "originalFormat": "modern"
      },
      "standardizedRegimens": []
    }
  },
  "laboratoryData": {
    "sources": [
      "laboratoryProfile"
    ],
    "value": {
      "testingIndications": [],
      "methodologyNotes": [
        "Phenotypic methods are used to detect carbapenemase-producing bacteria in the clinical laboratory."
      ],
      "recommendedPanel": [],
      "specialTests": [],
      "reportingRules": [],
      "antimicrobialBreakpoints": []
    }
  },
  "additionalData": {
    "antimicrobialStewardship": {
      "sources": [
        "antimicrobial_stewardship",
        "antimicrobialStewardship"
      ],
      "value": []
    },
    "comments": {
      "preservedStructure": {
        "originalFormat": "object"
      }
    },
    "diagnosis": {
      "sources": [
        "diagnosis"
      ],
      "value": []
    },
    "allOtherKeys": {}
  }
}